Anne-Catherine Wéra

Anne-Catherine Wéra

Auto-generated profile, based on publicly available information

Anne-Catherine Wéra

Laboratory of Biochemistry and Cell Biology (URBC), Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
EBEmilie Bauwens
Emilie Bauwens
TPTom Parée
Tom Parée
SMSebastien Meurant
Sebastien Meurant
IBInès Bouriez
Inès Bouriez
CHClotilde Hannart
Clotilde Hannart
FCFlorence Chainiaux
Florence Chainiaux

24 September 2025 in Physics and Imaging in Radiation Oncology
Verified
Journal Article
Open access
MVMacarena Chocan Vera
Macarena Chocan Vera
AWAnne-Catherine Wéra
Anne-Catherine Wéra
HOHamdiye Ozan
Hamdiye Ozan
EEErik Engwall
Erik Engwall
VWViktor Wase
Viktor Wase
ESEdmond Sterpin
Edmond Sterpin
Particle Arc Therapy (PAT) is considered a promising technique to improve conformity and reduce toxicities. Robustly optimized PAT plans were evaluated versus Intensity Modulated Proton Therapy (IMPT) for oesophageal cancer in 17 patients. Impact of motion, setup and range uncertainties on target coverage, plan quality and Organs At Risk (OAR) doses were assessed. PAT (two 80°–200°arcs) reduced OAR doses (spinal canal D0.05cm3: 5.12 Gy (12.8%), lungs and heart Dmean: 0.39 Gy (8.8%) and 0.83 Gy (10.5%)) while maintaining robustness. Similar toxicities were observed, but delivery time was doubled for PAT, indicating that further development is needed.